Zobrazeno 51 - 60
of 23 592
pro vyhledávání: ''
Autor:
Yoshihiro, Araki, Norio, Yamamoto, Toru, Maeda, Hiroaki, Kimura, Takashi, Ota, Shingo, Shimozaki, Takashi, Kato, Daisuke, Inoue, Takashi, Higuchi, Kensaku, Abe, Yuta, Taniguchi, Hiroyuki, Tsuchiya
Publikováno v:
Anticancer Research. 42:1555-1562
The management of soft-tissue tumors of 2-5 cm is not specified. We investigated the management of these cases.Among 105 cases with soft-tissue tumors from 2014 to 2021, 38 with tumors of 2-5 cm were retrospectively reviewed. The clinical characteris
Autor:
Yasuro, Futagawa, Shinji, Onda, Shuichi, Fujioka, Teruyuki, Usuba, Yukio, Nakabayashi, Takeyuki, Misawa, Tomoyoshi, Okamoto, Toru, Ikegami
Publikováno v:
Anticancer Research. 42:1579-1588
Management strategies for pseudoaneurysm rupture after pancreatic resection have not yet been firmly established due to its low incidence and effects of environmental variability among centers. This study aimed to provide a basis for treatment strate
Autor:
TAKEHIRO OTOSHI, TATSUYA NAGANO, JONGUK PARK, KOJI HOSOMI, TOMOYA YAMASHITA, MOTOKO TACHIHARA, TOKIKO TABATA, REINA SEKIYA, YUGO TANAKA, KAZUYUKI KOBAYASHI, KENJI MIZUGUCHI, TOMOO ITOH, YOSHIMASA MANIWA, JUN KUNISAWA, YOSHIHIRO NISHIMURA
Publikováno v:
Anticancer Research. 42:1589-1598
The gut microbiome plays an important role in the immune system and has attracted attention as a biomarker of several diseases, including cancer. In this study, we examined the relationship between the gut microbiome and lung cancer progression.Femal
Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab
Autor:
Hideaki, Suematsu, Kazuki, Kano, Takanobu, Yamada, Itaru, Hashimoto, Hayato, Watanabe, Kosuke, Takahashi, Mamoru, Watanabe, Kei, Hayashi, Yoshihiro, Kaneta, Mitsuhiro, Furuta, Yasuhiro, Inokuchi, Nozomu, Machida, Toru, Aoyama, Hiroshi, Tamagawa, Norio, Yukawa, Yasushi, Rino, Munetaka, Masuda, Takashi, Ogata, Takashi, Oshima
Publikováno v:
Anticancer Research. 42:1535-1540
To evaluate the impact of development of nivolumab monotherapy-induced immune-related adverse events (irAEs) and continuing nivolumab with irAEs on the survival of patients with gastric cancer (GC).Patients with unresectable advanced GC and recurrenc
Autor:
CHIARA CICCARESE, ROBERTO IACOVELLI, SEBASTIANO BUTI, FRANCESCA PRIMI, SERENA ASTORE, FRANCESCO MASSARI, MIRIAM GRAZIA FERRARA, GIUSEPPE PALERMO, NAZARIO FOSCHI, VALERIO IACOVELLI, ERNESTO ROSSI, GIOVANNI SCHINZARI, PIERLUIGI BOVE, PIERFRANCESCO BASSI, EMILIO BRIA, GIAMPAOLO TORTORA
Publikováno v:
Anticancer Research. 42:1487-1493
Recent evidence suggests potential synergistic antitumor effects of the combination of programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) immune checkpoint inhibitors with the oral hypoglycemic agent metformin. The aim of this study was to i
Autor:
TAKURO OKADA, CHIHIRO FUSHIMI, TAKASHI MATSUKI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KUNIHIKO TOKASHIKI, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, YUSUKE AIHARA, KENJI HANYU, YUKIOMI KUSHIHASHI, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, YUKI HARADA, KAHO MOMIYAMA, TAKU YAMASHITA, GO OMURA, HIDEAKI TAKAHASHI, NOBUHIKO ORIDATE, KIYOAKI TSUKAHARA
Publikováno v:
Anticancer Research. 42:1607-1613
There are no real-world comparative data of nivolumab doses of 3 mg/kg and 240 mg/body for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). We investigated the efficacy and safety of nivolumab in treating recurrent/metas
Autor:
Nobuki, Furubayashi, Futoshi, Morokuma, Toshihisa, Tomoda, Yoshifumi, Hori, Takahito, Negishi, Akihiro, Miura, Hiroki, Komori, Kentaro, Kuroiwa, Motonobu, Nakamura
Publikováno v:
Anticancer Research. 42:1571-1577
The optimal timing of switching from platinum-based chemotherapy to pembrolizumab in patients with advanced urothelial carcinoma (UC) remains unclear.Thirty-four patients who received pembrolizumab as second-line treatment after first-line platinum-b
Autor:
Manato, Ohsawa, Yoichi, Hamai, Manabu, Emi, Yuta, Ibuki, Tomoaki, Kurokawa, Toru, Yoshikawa, Ryosuke, Hirohata, Nao, Kitasaki, Morihito, Okada
Publikováno v:
Anticancer Research. 42:1499-1507
Trimodal therapy is frequently used for patients with locally advanced, resectable oesophageal cancer. However, it does not provide a satisfactory prognosis. The neutrophil-to-lymphocyte ratio (NLR) is an important indicator of patients' inflammatory
Publikováno v:
Anticancer Research. 42:1359-1365
To investigate the association between external beam radiotherapy (EBRT) and the incidence of second primary tumors in patients with thyroid cancer.Data were extracted from the Surveillance, Epidemiology, and End Results 9 database. The study cohort
Autor:
Paul E. Wakely
Publikováno v:
Cancer Cytopathology. 130:443-454
Mesenchymal neoplasms of the parotid gland (PG) and para-pharyngeal (PP) space are distinctly uncommon. Fine-needle aspiration (FNA) biopsy experience with nonlipomatous neoplasms from this site is reviewed.Cytopathology and surgical pathology files